DUBLIN--(BUSINESS WIRE)--The "World Microbiome Therapeutics Market - Opportunities and Forecasts, 2014 - 2022" report has been added to Research and Markets' offering.
The Human Microbiome refers to the group of microorganisms that reside on skin layers, and in saliva, conjunctiva, oral mucosa and the gastrointestinal tract (GIT). It includes bacteria, archaea and fungi. Despite being parasites, these microorganisms perform tasks which are beneficial for the human host in maintaining health.
The human microbiome has fascinated researchers in the past few years due to the usefulness of these microorganisms in terms of health maintenance and treatment of certain diseases. The Human Microbiome Project, which was conducted in 2012, reported that more than 10,000 microbial species live in the human ecosystem and comprise trillions of cells, making up 1%-3% of the total body mass.
Conversely, microorganisms that are omnipresent in humans can sometimes turn virulent and cause sickness or even death. Researchers are focusing on improving the efficiency of medical treatments by developing a therapeutics course comprising of a subset of microorganisms.
These research studies are currently under clinical development and are expected to fuel the market growth in the near future. Advancement in microbiome technologies would assist in determining the probable solutions for serious diseases; these technologies would thus improve healthcare outcomes.
MicroBiome Therapeutics LLC, Enterome Bioscience, Pfizer and Johnson & Johnson are some of the key players in this market. Enterome has developed a diagnostic tool for the detection of inflammatory bowel disease by using a genetic sequencing platform.
The global microbiome therapeutics market is segmented on the basis of application and geography. Microbiome has various applications, such as Inflammatory Bowel Disease, Diabetes, Multiple Sclerosis, Rheumatoid Arthritis and Others.
KEY MARKET SEGMENTS
MARKET BY APPLICATION
- Inflammatory Bowel Disease
- Diabetes
- Multiple Sclerosis
- Rheumatoid Arthritis
-
Others
MARKET BY GEOGRAPHY
- North America
- Europe
- Asia-Pacific
-
LAMEA
For more information about this report visit https://www.researchandmarkets.com/research/z7dgqs/world_microbiome
